Abstract
Although a genetically engineered version of the HIV surface protein gp120 has proven ineffective in efficacy trials, an ambitious new study in Thailand has just started to assess whether it might provide an effective boost to another AIDS vaccine.

This publication has 0 references indexed in Scilit: